Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiMal
PACTR202008909968293Phase 2Completed
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of artesunate, pyronaridine, atovaquone, proguanil, fosmidomycin and 1 more in malaria and Malaria (3 arms), sponsored by Bernhard Nocht Institute for Tropical Medicine. Primary endpoint: Pharmacokinetic properties of partner drugs and principal active metabolites. Started Oct 2019; status: completed.
02
Drugs
artesunatepyronaridineatovaquoneproguanilfosmidomycin
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202008909968293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008909968293.